Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Clinical trial NCT03242252 · COMPLETED

Trial details

NCT number

NCT03242252

Sponsor

Lexicon Pharmaceuticals

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2017-08-16

Primary completion

2019-03-25

Enrollment

787

View on ClinicalTrials.gov